원격 피부과 시장 규모, 점유율, 동향 분석 보고서(2025-2030년) : 모달리티별, 서비스별, 최종 용도별, 지역별 부문 예측

Teledermatology Market Growth & Trends:

The global teledermatology market size is anticipated to reach USD 41.08 billion by 2030 and is projected to grow at a CAGR of 17.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is expected to grow due to the increasing smartphone adoption, rising prevalence of skin illnesses and skin-related issues, increased acceptance of telemedicine platforms, and growing internet penetration globally. As per WHO study published in March 2023, Skin conditions are a significant global health issue, affecting approximately 1.8 billion people at any given time. This statistic highlights the prevalence of various skin disorders, which can range from mild irritations to severe infections and chronic diseases.

Teledermatology offers a convenient, accessible way for patients to receive dermatological consultations remotely, leveraging technology to bridge the gap between patients and specialists. It allows patients to submit images of their skin conditions through secure platforms, where dermatologists can review and provide a diagnosis or treatment plan. This model improves access to care, particularly for those in rural or underserved areas, reduces wait times, and can help in early detection of skin diseases, including skin cancer. In addition, teledermatology can offer a cost-effective alternative to in-person visits while maintaining the quality and accuracy of medical care.

Moreover, the increasing usage of tele-dermatology platforms is the rising number of smartphone users and expanding internet access globally. According to the International Telecommunication Union, around 5 billion people have access to the internet, and most of them use smartphones to do it. In addition, the main market players' efforts in digital marketing and social media marketing to expand their consumer bases have increased as a result of the social media's increasing penetration. The availability of dermatologists and consultants on teledermatology platforms has increased due to the growing consumer use of telehealth.

Teledermatology Market Report Highlights:

• Based on modalities, the store and forward segment held the largest market share in 2024. This is attributed to store-and-forward technique which has become crucial for accurately recording skin photos.
• Based on service, the teleconsultation segment held the largest market share in 2024. This can be attributed to the two advancements in artificial intelligence (AI) and machine learning.
• Based on end use, the patients segment held the largest market share in 2024. This can be attributed to the fact that patients use telemedicine services for a variety of reasons, from minor to major situations.
• For instance, in December 2024, Omda AS, announced its acquisition of Dermicus AB, a company that specializes in telemedicine solutions focused on teledermatology and telewound care.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. Service outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Teledermatology Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing Burden of Skin Diseases
    • 3.2.1.2. Increasing Adoption of Telehealth
    • 3.2.1.3. Rising Demand for Remote Care
    • 3.2.1.4. Availability of Secure Communication Platforms
    • 3.2.1.5. Advancements in Remote Diagnostics
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Limited Reimbursement Policies
    • 3.2.2.2. Legal and Regulatory Challenges
    • 3.2.2.3. Concerns Over Privacy and Security
• 3.3. Teledermatology: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier Power
    • 3.3.1.2. Buyer Power
    • 3.3.1.3. Substitution Threat
    • 3.3.1.4. Threat of New Entrants
    • 3.3.1.5. Competitive Rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic Landscape
    • 3.3.2.3. Social Landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Legal Landscape
    • 3.3.2.6. Environmental Landscape
• 3.4. Regulatory Landscape in the Market
• 3.5. Technology Scenario for the Market

Chapter 4. Teledermatology Market Segment Analysis, By Modalities, 2018 - 2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Modalities Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Teledermatology Market, by Modalities, 2018 to 2030
• 4.5. Live Video
  • 4.5.1. Live Video Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Store-and-Forward
  • 4.6.1. Store-and-Forward Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Hybrid
  • 4.7.1. Hybrid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Teledermatology Market Segment Analysis, By Services, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Services Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Teledermatology Market, by Services, 2018 to 2030
• 5.5. Teleconsultation
  • 5.5.1. Teleconsultation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Telemonitoring
  • 5.6.1. Telemonitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Tele-education
  • 5.7.1. Tele-education Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Teledermatology Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Teledermatology Market, by End Use, 2018 to 2030
• 6.5. Providers
  • 6.5.1. Providers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Patients
  • 6.6.1. Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Teledermatology Market Segment Analysis, By Region, 2018- 2030 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Teledermatology Market Share by Region, 2024 & 2030:
• 7.5. North America
  • 7.5.1. North America teledermatology market, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. teledermatology market, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada teledermatology market, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico teledermatology market, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden teledermatology market, 2018 - 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark teledermatology market, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan teledermatology market, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China teledermatology market, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India teledermatology market, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia teledermatology market, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea teledermatology market, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Regulatory Scenario
    • 7.7.6.3. Competitive Scenario
    • 7.7.6.4. Thailand teledermatology market, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil teledermatology market, 2018 - 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina teledermatology market, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa teledermatology market, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia teledermatology market, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE teledermatology market, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait teledermatology market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Teladoc Health, Inc.
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Platform benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. American Well
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Platform benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. MDLIVE
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Platform benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. 3Derm
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Platform benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. Doctor On Demand
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Platform benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. Miiskin
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Platform benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. MetaOptima Technology Inc.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Platform benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. VisualDx
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Platform benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. Digital Diagnostics Inc.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Platform benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. Ksyos
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Platform benchmarking
    • 8.3.10.4. Strategic initiatives
  • 8.3.11. CureSkin
    • 8.3.11.1. Company overview
    • 8.3.11.2. Financial performance
    • 8.3.11.3. Platform benchmarking
    • 8.3.11.4. Strategic initiatives